Main variables;Fields of operation;Total
Units that perform R+D in Biotechnology;Total;1,332
Units that perform R+D in Biotechnology;Units;1,133
Units that perform R+D in Biotechnology;P.A.;120
Units that perform R+D in Biotechnology;Higher Education;67
Units that perform R+D in Biotechnology;PNPI;12
%Units according to biotechnology used: Genetic code;Total;41
%Units according to biotechnology used: Genetic code;Units;33
%Units according to biotechnology used: Genetic code;P.A.;88
%Units according to biotechnology used: Genetic code;Higher Education;87
%Units according to biotechnology used: Genetic code;PNPI;33
%Units according to biotechnology used: Functional units;Total;48
%Units according to biotechnology used: Functional units;Units;41
%Units according to biotechnology used: Functional units;P.A.;89
%Units according to biotechnology used: Functional units;Higher Education;91
%Units according to biotechnology used: Functional units;PNPI;50
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Total;31
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Units;24
%Units according to biotechnology used: Cellular and tissue culturing and engineering;P.A.;74
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Higher Education;82
%Units according to biotechnology used: Cellular and tissue culturing and engineering;PNPI;50
%Units according to biotechnology used: Bioprocesses;Total;53
%Units according to biotechnology used: Bioprocesses;Units;50
%Units according to biotechnology used: Bioprocesses;P.A.;61
%Units according to biotechnology used: Bioprocesses;Higher Education;93
%Units according to biotechnology used: Bioprocesses;PNPI;42
%Units according to biotechnology used: Sub-cellular organisms;Total;14
%Units according to biotechnology used: Sub-cellular organisms;Units;6
%Units according to biotechnology used: Sub-cellular organisms;P.A.;56
%Units according to biotechnology used: Sub-cellular organisms;Higher Education;72
%Units according to biotechnology used: Sub-cellular organisms;PNPI;33
%Units according to biotechnology used: Bio-computing;Total;31
%Units according to biotechnology used: Bio-computing;Units;24
%Units according to biotechnology used: Bio-computing;P.A.;69
%Units according to biotechnology used: Bio-computing;Higher Education;85
%Units according to biotechnology used: Bio-computing;PNPI;8
%Units according to biotechnology used: Nanobiotechnology;Total;19
%Units according to biotechnology used: Nanobiotechnology;Units;13
%Units according to biotechnology used: Nanobiotechnology;P.A.;50
%Units according to biotechnology used: Nanobiotechnology;Higher Education;70
%Units according to biotechnology used: Nanobiotechnology;PNPI;8
%Units according to biotechnology used: Other;Total;14
%Units according to biotechnology used: Other;Units;14
%Units according to biotechnology used: Other;P.A.;8
%Units according to biotechnology used: Other;Higher Education;18
%Units according to biotechnology used: Other;PNPI;8
Units in which biotechnology activities are:  Main and/or exclusive;Total;647
Units in which biotechnology activities are:  Main and/or exclusive;Units;603
Units in which biotechnology activities are:  Main and/or exclusive;P.A.;33
Units in which biotechnology activities are:  Main and/or exclusive;Higher Education;5
Units in which biotechnology activities are:  Main and/or exclusive;PNPI;6
Units in which biotechnology activities are: A secondary line of business;Total;252
Units in which biotechnology activities are: A secondary line of business;Units;173
Units in which biotechnology activities are: A secondary line of business;P.A.;39
Units in which biotechnology activities are: A secondary line of business;Higher Education;38
Units in which biotechnology activities are: A secondary line of business;PNPI;2
Units in which biotechnology activities are: A tool necessary for production;Total;433
Units in which biotechnology activities are: A tool necessary for production;Units;357
Units in which biotechnology activities are: A tool necessary for production;P.A.;48
Units in which biotechnology activities are: A tool necessary for production;Higher Education;24
Units in which biotechnology activities are: A tool necessary for production;PNPI;4
%Units by field(s) of ultimate application of biotechnology use: Human health;Total;51
%Units by field(s) of ultimate application of biotechnology use: Human health;Units;45
%Units by field(s) of ultimate application of biotechnology use: Human health;P.A.;78
%Units by field(s) of ultimate application of biotechnology use: Human health;Higher Education;91
%Units by field(s) of ultimate application of biotechnology use: Human health;PNPI;58
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;20
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Units;18
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;P.A.;15
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Higher Education;67
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;PNPI;8
%Units by field(s) of ultimate application of biotechnology use: Food products;Total;32
%Units by field(s) of ultimate application of biotechnology use: Food products;Units;31
%Units by field(s) of ultimate application of biotechnology use: Food products;P.A.;20
%Units by field(s) of ultimate application of biotechnology use: Food products;Higher Education;79
%Units by field(s) of ultimate application of biotechnology use: Food products;PNPI;8
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Total;24
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Units;22
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;P.A.;19
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Higher Education;73
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;PNPI;25
%Units by field(s) of ultimate application of biotechnology use: Environment;Total;17
%Units by field(s) of ultimate application of biotechnology use: Environment;Units;14
%Units by field(s) of ultimate application of biotechnology use: Environment;P.A.;22
%Units by field(s) of ultimate application of biotechnology use: Environment;Higher Education;72
%Units by field(s) of ultimate application of biotechnology use: Environment;PNPI;17
%Units by field(s) of ultimate application of biotechnology use: Industry;Total;15
%Units by field(s) of ultimate application of biotechnology use: Industry;Units;12
%Units by field(s) of ultimate application of biotechnology use: Industry;P.A.;12
%Units by field(s) of ultimate application of biotechnology use: Industry;Higher Education;67
%Units by field(s) of ultimate application of biotechnology use: Industry;PNPI;8
Personnel in R&D in biotechnology (no. of persons);Total;40,018
Personnel in R&D in biotechnology (no. of persons);Units;11,510
Personnel in R&D in biotechnology (no. of persons);P.A.;13,944
Personnel in R&D in biotechnology (no. of persons);Higher Education;14,415
Personnel in R&D in biotechnology (no. of persons);PNPI;149
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;26,603
Personnel in R&D in biotechnology (no. of persons): Researchers;Units;6,202
Personnel in R&D in biotechnology (no. of persons): Researchers;P.A.;8,687
Personnel in R&D in biotechnology (no. of persons): Researchers;Higher Education;11,634
Personnel in R&D in biotechnology (no. of persons): Researchers;PNPI;80
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;13,415
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Units;5,308
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;P.A.;5,257
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Higher Education;2,781
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;PNPI;69
Personnel in R&D in biotechnology (no. of persons): women;Total;22,240
Personnel in R&D in biotechnology (no. of persons): women;Units;6,389
Personnel in R&D in biotechnology (no. of persons): women;P.A.;8,590
Personnel in R&D in biotechnology (no. of persons): women;Higher Education;7,165
Personnel in R&D in biotechnology (no. of persons): women;PNPI;96
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;13,936
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Units;3,304
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;P.A.;5,040
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Higher Education;5,545
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;PNPI;47
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;8,305
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Units;3,086
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;P.A.;3,550
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Higher Education;1,620
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;PNPI;49
Personnel in R&D in biotechnology (FTE);Total;27,550.6
Personnel in R&D in biotechnology (FTE);Units;8,236.9
Personnel in R&D in biotechnology (FTE);P.A.;10,492.6
Personnel in R&D in biotechnology (FTE);Higher Education;8,726.3
Personnel in R&D in biotechnology (FTE);PNPI;94.8
Personnel in R&D in biotechnology (FTE): Researchers;Total;17,572.9
Personnel in R&D in biotechnology (FTE): Researchers;Units;4,596.1
Personnel in R&D in biotechnology (FTE): Researchers;P.A.;6,124.4
Personnel in R&D in biotechnology (FTE): Researchers;Higher Education;6,798.1
Personnel in R&D in biotechnology (FTE): Researchers;PNPI;54.3
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;9,977.7
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Units;3,640.8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;P.A.;4,368.2
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Higher Education;1,928.2
Personnel in R&D in biotechnology (FTE): Technicians and assistants;PNPI;40.5
Personnel in R&D in biotechnology (FTE): women;Total;15,792.1
Personnel in R&D in biotechnology (FTE): women;Units;4,698.5
Personnel in R&D in biotechnology (FTE): women;P.A.;6,519.9
Personnel in R&D in biotechnology (FTE): women;Higher Education;4,509.0
Personnel in R&D in biotechnology (FTE): women;PNPI;64.7
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;9,524.4
Personnel in R&D in biotechnology (FTE): (women) Researchers;Units;2,512.5
Personnel in R&D in biotechnology (FTE): (women) Researchers;P.A.;3,603.3
Personnel in R&D in biotechnology (FTE): (women) Researchers;Higher Education;3,374.3
Personnel in R&D in biotechnology (FTE): (women) Researchers;PNPI;34.3
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;6,267.7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Units;2,186.0
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;P.A.;2,916.6
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Higher Education;1,134.7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;PNPI;30.4
Internal expenditure on R&D (thousands of euros);Total;1,783,011
Internal expenditure on R&D (thousands of euros);Units;769,431
Internal expenditure on R&D (thousands of euros);P.A.;596,928
Internal expenditure on R&D (thousands of euros);Higher Education;411,163
Internal expenditure on R&D (thousands of euros);PNPI;5,489
1) By nature of the expense: Current expenses;Total;1,673,710
1) By nature of the expense: Current expenses;Units;719,715
1) By nature of the expense: Current expenses;P.A.;567,086
1) By nature of the expense: Current expenses;Higher Education;381,526
1) By nature of the expense: Current expenses;PNPI;5,383
1.1) Remuneration to researchers;Total;677,784
1.1) Remuneration to researchers;Units;221,447
1.1) Remuneration to researchers;P.A.;225,782
1.1) Remuneration to researchers;Higher Education;228,981
1.1) Remuneration to researchers;PNPI;1,573
1.2) Remuneration to technicians and assistants;Total;290,584
1.2) Remuneration to technicians and assistants;Units;122,809
1.2) Remuneration to technicians and assistants;P.A.;107,902
1.2) Remuneration to technicians and assistants;Higher Education;58,884
1.2) Remuneration to technicians and assistants;PNPI;989
1.3) Other current expenses;Total;705,342
1.3) Other current expenses;Units;375,459
1.3) Other current expenses;P.A.;233,402
1.3) Other current expenses;Higher Education;93,661
1.3) Other current expenses;PNPI;2,820
2) By nature of the expense: Capital expenses;Total;109,301
2) By nature of the expense: Capital expenses;Units;49,715
2) By nature of the expense: Capital expenses;P.A.;29,842
2) By nature of the expense: Capital expenses;Higher Education;29,637
2) By nature of the expense: Capital expenses;PNPI;106
2.1) Land and buildings;Total;18,585
2.1) Land and buildings;Units;9,521
2.1) Land and buildings;P.A.;3,511
2.1) Land and buildings;Higher Education;5,553
2.1) Land and buildings;PNPI;0
2.2) Equipment and instruments;Total;78,285
2.2) Equipment and instruments;Units;30,466
2.2) Equipment and instruments;P.A.;25,115
2.2) Equipment and instruments;Higher Education;22,598
2.2) Equipment and instruments;PNPI;106
2.3) Acquisition of specific R+D software;Total;4,139
2.3) Acquisition of specific R+D software;Units;1,810
2.3) Acquisition of specific R+D software;P.A.;1,014
2.3) Acquisition of specific R+D software;Higher Education;1,314
2.3) Acquisition of specific R+D software;PNPI;1
2.4) Otros productos de propiedad intelectual específicos para I+D;Total;8,292
2.4) Otros productos de propiedad intelectual específicos para I+D;Units;7,919
2.4) Otros productos de propiedad intelectual específicos para I+D;P.A.;202
2.4) Otros productos de propiedad intelectual específicos para I+D;Higher Education;172
2.4) Otros productos de propiedad intelectual específicos para I+D;PNPI;0
1.1) By origin of the funds: Own funds;Total;639,755
1.1) By origin of the funds: Own funds;Units;490,913
1.1) By origin of the funds: Own funds;P.A.;69,873
1.1) By origin of the funds: Own funds;Higher Education;78,383
1.1) By origin of the funds: Own funds;PNPI;585
1.2) By origin of the funds: From companies;Total;189,495
1.2) By origin of the funds: From companies;Units;82,548
1.2) By origin of the funds: From companies;P.A.;77,770
1.2) By origin of the funds: From companies;Higher Education;28,349
1.2) By origin of the funds: From companies;PNPI;828
1.3) By origin of the funds: Public Administration funds;Total;737,076
1.3) By origin of the funds: Public Administration funds;Units;96,809
1.3) By origin of the funds: Public Administration funds;P.A.;379,076
1.3) By origin of the funds: Public Administration funds;Higher Education;258,952
1.3) By origin of the funds: Public Administration funds;PNPI;2,239
1.4) By origin of the funds: From Universities;Total;2,962
1.4) By origin of the funds: From Universities;Units;197
1.4) By origin of the funds: From Universities;P.A.;1,380
1.4) By origin of the funds: From Universities;Higher Education;1,309
1.4) By origin of the funds: From Universities;PNPI;75
1.5) By origin of the funds: From non profit private institutions;Total;24,088
1.5) By origin of the funds: From non profit private institutions;Units;4,766
1.5) By origin of the funds: From non profit private institutions;P.A.;11,426
1.5) By origin of the funds: From non profit private institutions;Higher Education;6,679
1.5) By origin of the funds: From non profit private institutions;PNPI;1,217
1.6) By origin of the funds: Foreign funds;Total;189,635
1.6) By origin of the funds: Foreign funds;Units;94,197
1.6) By origin of the funds: Foreign funds;P.A.;57,401
1.6) By origin of the funds: Foreign funds;Higher Education;37,492
1.6) By origin of the funds: Foreign funds;PNPI;545
Purchase of services R & D in Biotechnology to (thousands of euros);Total;153,607
Purchase of services R & D in Biotechnology to (thousands of euros);Units;120,281
Purchase of services R & D in Biotechnology to (thousands of euros);P.A.;26,850
Purchase of services R & D in Biotechnology to (thousands of euros);Higher Education;6,101
Purchase of services R & D in Biotechnology to (thousands of euros);PNPI;375
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Total;98,024
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Units;69,564
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;P.A.;22,379
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Higher Education;5,769
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;PNPI;312
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Total;55,583
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Units;50,718
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;P.A.;4,470
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Higher Education;332
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;PNPI;63
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;47
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Units;45
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;P.A.;59
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Higher Education;58
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;PNPI;75
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;12
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Units;12
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;P.A.;3
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Higher Education;12
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;PNPI;25
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;20
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Units;16
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;P.A.;41
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Higher Education;40
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;PNPI;33
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;16
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Units;14
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;P.A.;28
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Higher Education;36
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;PNPI;25
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total;19
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Units;16
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;P.A.;33
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Higher Education;43
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;PNPI;33
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Total;20
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Units;18
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;P.A.;30
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Higher Education;40
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;PNPI;25
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total;15
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Units;15
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;P.A.;11
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Higher Education;11
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;PNPI;33
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;37
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Units;37
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;P.A.;42
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Higher Education;34
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;PNPI;42
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Total;53
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Units;52
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;P.A.;61
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Higher Education;61
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;PNPI;58
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;20
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Units;20
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;P.A.;20
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Higher Education;19
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;PNPI;25
%Units that have requested biotechnology patents in Biotechnology;Total;21
%Units that have requested biotechnology patents in Biotechnology;Units;15
%Units that have requested biotechnology patents in Biotechnology;P.A.;45
%Units that have requested biotechnology patents in Biotechnology;Higher Education;75
%Units that have requested biotechnology patents in Biotechnology;PNPI;8
Number of patents requested;Total;1,785
Number of patents requested;Units;681
Number of patents requested;P.A.;555
Number of patents requested;Higher Education;548
Number of patents requested;PNPI;1